Nature Biotechnology 2000 Alan Dove - Abstracts

Nature Biotechnology 2000 Alan Dove
TitleSubjectAuthors
CD18 trials disappoint again.(Genentech monoclonal antibodies)BusinessAlan Dove
Experts disagree over color of biomass.BusinessAlan Dove
Opinions evolve on Kauffman patent.BusinessAlan Dove
Opinions evolve on Kauffman patent.(Brief Article)BusinessAlan Dove
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.